On October 31, 2019 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, reported its participation at two upcoming conferences in November (Press release, Hookipa Pharma, OCT 31, 2019, View Source [SID1234553430]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

6th BioCentury-BayHelix China Healthcare Summit in Shanghai: HOOKIPA will present on Tuesday, November 19, 2019, at 4:15 pm China Standard Time (CST) in Ballroom II and participate in 1×1 meetings

Jefferies 2019 Healthcare Conference in London, November 20, 2019: HOOKIPA will participate in 1×1 meetings with investors.
Additional information will be available within the Investors & Media section of HOOKIPA’s website at View Source